Doubling of Risk for Bleeding With Sorafenib and Sunitinib
This is a discussion on Doubling of Risk for Bleeding With Sorafenib and Sunitinib within the Other Clinical Pharmacy News forum, part of the Industry News and Updates category; A new meta-analysis, which involved 6779 patients, found a statistically increased risk for all grades of bleeding events with ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
10-27-2009, 01:09 PM
|
|||
|
|||
Doubling of Risk for Bleeding With Sorafenib and Sunitinib
A new meta-analysis, which involved 6779 patients, found a statistically increased risk for all grades of bleeding events with these targeted agents.
Medscape Medical News More... 
|
 |
«
Previous Thread
|
Next Thread
»
| Thread Tools | |
| Display Modes | |
Linear Mode
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| STEMI Patients in TRITON-TIMI 38: Prasugrel Bests Clopidogrel Without Bleeding Risk | industry_news | Other Clinical Pharmacy News | 0 | 02-27-2009 06:09 PM |
| Enoxaparin, Heparin Linked to High Bleeding Risk in Cardioembolic Stroke | industry_news | Other Clinical Pharmacy News | 0 | 07-21-2008 06:40 PM |
| Enoxaparin, Heparin Linked to High Bleeding Risk in Cardioembolic Stroke | industry_news | Other Clinical Pharmacy News | 0 | 07-18-2008 11:11 AM |
| SSRIs and Venlafaxine Linked to Greater Risk for Gastrointestinal Tract Bleeding | industry_news | Other Clinical Pharmacy News | 0 | 07-14-2008 06:31 PM |
| Off-Label Uses of Sorafenib and Sunitinib | industry_news | Updates from the Technology Assessment Authorities | 0 | 03-10-2008 04:01 PM |
© 2008 DrugManagementForum™ powered by |
 |